Project Grant R01NS134747
Award Date
8/1/24
Completion Date
6/30/29
Dollars Obligated
$512K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $227,018 to the University of California, Irvine (UCI) from May 1, 2025 to April 30, 2027. The project aims to determine the role of microglia, brain-resident immune cells, in defending against Toxoplasma gondii infection in the context of AIDS-associated immune deficiency. Key objectives include examining...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $269,054 to the University of California, Merced to conduct research on mechanisms that determine disease outcome following primary infection with the parasite Toxoplasma gondii in mice. The researchers aim to leverage the genetically diverse Collaborative Cross mouse panel and parasite genetics to identify novel...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $563,513.00 to Arizona State University to conduct research on the patterning, growth, and maturation of cortical microtubules in the apicomplexan parasite Toxoplasma. The research aims to explore the initiation of microtubule patterning, their growth and maturation, with the goal of identifying new drug...
This Project Grant award of $176,537 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to investigate the role of reactive oxygen species (ROS) in controlling acute Toxoplasma gondii infection. The key objectives are to: 1) determine the cellular events and receptors involved in inducing ROS production in T. gondii-infected neutrophils, 2) identify whether ROS is mediated through...
This Project Grant award of $582,883, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the role of CAS adaptor proteins during cortical axon pathfinding and the development of proper connections in the brain. The award, granted to the Regents of the University of California at Riverside, aims to increase understanding of how...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $515,875 to the University of Florida to conduct research on the mechanisms underlying Cryptococcus neoformans-induced meningoencephalitis and neurotoxicity in a CD4 T cell-deficient mouse model. The goal is to elucidate how the Cryptococcus polysaccharide capsule component glucuronoxylomannan (GXM) affects basal...
This Project Grant award for $665,171.00, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to improve outcomes for individuals with HIV-associated opportunistic infections like cryptococcal and TB meningitis. The key objectives are to: 1) define CSF drug concentrations or AUC/MIC ratios that predict fungal clearance, 2) determine the relationship between...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a 2-year, $544,500 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to the Texas Biomedical Research Institute to characterize a novel mouse model for studying the neurological impacts of Chikungunya virus infection. The research aims to determine the mechanisms by which Chikungunya virus infects the brain and evaluate whether the mouse model develops the...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $808,216 to Boston Children's Hospital to conduct comprehensive studies on the molecular mechanisms of tetanus neurotoxin pathogenesis. The research aims to identify host factors that mediate the trafficking of tetanus neurotoxin into the spinal cord, a century-old mystery in understanding tetanus etiology. The...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $794,967 to Augusta University Research Institute, Inc. to develop a murine glioblastoma model for evaluating oncolytic herpes simplex virus (HSV) therapy. The goal is to create an immune-competent mouse model that is permissive to HSV-1 infection, exhibits reproducible...